1. Medtech Insight
  2. >>Geography
  3. >>Europe
  4. >>United Kingdom

COVID-19: UK NHS Chief Calls For 90% Return To Planned Care Within 3 Months

 
• By Ashley Yeo

The much-anticipated return to a “normal” NHS service delivery could yet be dashed by a resurgence of the virus.

Royal_Free_Hospital

Embattled UK National Health Service chief executive Simon Stevens is encouraging a faster return to pre-COVID-19 level of planned and elective care service delivery. In a letter to NHS service heads, he set an aim of recovering the maximum elective activity possible between now and winter, using re-contracted independent hospitals to add to NHS capacity.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United Kingdom

Pushing On An Open EU Door? Time For MHRA To Get Practical About UK’s Regulatory Ambition

 
• By Ashley Yeo

The UK’s “New Approach” to regulation has created a lot of noise, but what’s the end product? asks Taylor Wessing partner Alison Dennis, who says the UK medtech regulator should look afresh at the EU’s ready-made solution.

UK Treading A Tightrope On Trump’s Tariffs

 
• By Ashley Yeo

Medtech has not yet been spared from the Trump administration’s trade tariffs, which, for UK exporters will be 10% – half the rate applied to EU27 exporters.

Owlstone Medical Develops P.aeruginosa Breath Test For Cystic Fibrosis Patients

 
• By Natasha Barrow

Cambridge, UK-based breath biopsy company Owlstone Medical will apply its volatile organic compound analysis platform in an attempt to develop a test for the identification and monitoring of pseudomonas aeruginosa in patients with cystic fibrosis.

Wired Health: Women Of Wearables Shares Market Outlook

 
• By Natasha Barrow

Medtech Insight sat down with Anja Streicher, chief marketing officer at Women of Wearables, a global community offering events and education resources to support the femtech industry, to discuss trends in the women's wearables tech market, challenges and innovators pushing the boundaries.

More from Europe

US Medtech Tariffs: How Will EU Navigate Unchartered Territory?

 
• By Amanda Maxwell

US President Trump has imposed sweeping tariffs that encompass medtech. These are expected to drive up costs, disrupt supply chains and hinder innovation, likely driving the EU to seek new trade partnerships to mitigate the impact.

UK Treading A Tightrope On Trump’s Tariffs

 
• By Ashley Yeo

Medtech has not yet been spared from the Trump administration’s trade tariffs, which, for UK exporters will be 10% – half the rate applied to EU27 exporters.

Swiss Blast US Import Tariffs As Medtechs Look For Dialog To Forestall Damage To Industry

 
• By Ashley Yeo

Swiss medtech exporters seek urgent diplomatic action from the Swiss Federal Council in a bid to overturn the 2 April US decision to put tariffs on goods imports.